{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:46:54Z","timestamp":1762508814724,"version":"3.37.3"},"reference-count":9,"publisher":"Oxford University Press (OUP)","issue":"40","license":[{"start":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T00:00:00Z","timestamp":1657584000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,21]]},"DOI":"10.1093\/eurheartj\/ehac358","type":"journal-article","created":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T03:36:25Z","timestamp":1657596985000},"page":"3991-3993","source":"Crossref","is-referenced-by-count":12,"title":["The cardiac sarcoidosis consortium: elucidating a mysterious disease through collaborative research"],"prefix":"10.1093","volume":"43","author":[{"given":"Jordana","family":"Kron","sequence":"first","affiliation":[{"name":"Pauley Heart Center, Virginia Commonwealth University , Richmond, VA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8525-8611","authenticated-orcid":false,"given":"Thomas","family":"Crawford","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan School of Medicine , 1500 East Medical Center Drive, SPC 5853 Ann Arbor, MI , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,7,12]]},"reference":[{"key":"2022102023574126000_ehac358-B1","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/europace\/eus316","article-title":"Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis","volume":"15","author":"Kron","year":"2013","journal-title":"Europace"},{"key":"2022102023574126000_ehac358-B2","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"key":"2022102023574126000_ehac358-B3","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0735-1097(22)01245-1","article-title":"Cardiac sarcoidosis patients who meet the 1993 and 2006 Japanese diagnostic criteria are more likely to have adverse outcomes","volume":"79","author":"Jasti","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2022102023574126000_ehac358-B4","doi-asserted-by":"crossref","first-page":"e024924","DOI":"10.1161\/JAHA.121.024924","article-title":"Arrhythmia monitoring and outcomes in patients with cardiac sarcoidosis: insights from the cardiac sarcoidosis consortium","author":"Bressi","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"2022102023574126000_ehac358-B5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/jamacardio.2021.4738","article-title":"Outcomes associated with catheter ablation of ventricular tachycardia in patients with cardiac sarcoidosis","volume":"7","author":"Siontis","year":"2022","journal-title":"JAMA Cardiol"},{"key":"2022102023574126000_ehac358-B6","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0735-1097(22)01244-X","article-title":"Traditional risk factors increase risk of poor outcomes in patients with cardiac sarcoidosis","volume":"79","author":"Jasti","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2022102023574126000_ehac358-B7","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.hrthm.2022.03.609","article-title":"Mortality and morbidity of cardiac sarcoidosis: an international registry","volume":"19","author":"Crawford","year":"2022","journal-title":"Heart Rhythm"},{"key":"2022102023574126000_ehac358-B8","doi-asserted-by":"crossref","first-page":"e007844","DOI":"10.1161\/JAHA.117.007844","article-title":"Hospitalization rates, prevalence of cardiovascular manifestations, and outcomes associated with sarcoidosis in the United States","volume":"7","author":"Patel","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2022102023574126000_ehac358-B9","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1186\/s12967-021-03130-8","article-title":"Interleukin-1 blockade in cardiac sarcoidosis: study design of the multimodality assessment of granulomas in cardiac sarcoidosis: anakinra randomized trial (MAGiC-ART)","volume":"19","author":"Kron","year":"2021","journal-title":"J Transl Med"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/43\/40\/3991\/46582375\/ehac358.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/43\/40\/3991\/46582375\/ehac358.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T23:58:17Z","timestamp":1666310297000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/43\/40\/3991\/6640038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,12]]},"references-count":9,"journal-issue":{"issue":"40","published-online":{"date-parts":[[2022,7,12]]},"published-print":{"date-parts":[[2022,10,21]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehac358","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"type":"print","value":"0195-668X"},{"type":"electronic","value":"1522-9645"}],"subject":[],"published-other":{"date-parts":[[2022,10,21]]},"published":{"date-parts":[[2022,7,12]]}}}